BIOPHARMAJOURNAL.COM: Keyword Density Checker

Total words: 3792 | 2-word phrases: 992 | 3-word phrases: 1083 | 4-word phrases: 1114

PAGE INFO

Title	Try to keep the title under 60 characters (45 characters) Home Page - Biotech Stocks - BioPharmaJournal
Description	Try to keep the meta description between 50 - 160 characters (29 characters) Latest News On Biotech Stocks
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	september 12 2024	7	0.65%
2	therapeutics secures 235	5	0.46%
3	235 million in	5	0.46%
4	on promising cancer	5	0.46%
5	promising cancer therapy	5	0.46%
6	cancer therapy licensing	5	0.46%
7	therapy licensing deal	5	0.46%
8	mnpr mnpr101zr shows	5	0.46%
9	therapeutics’ mnpr mnpr101zr	5	0.46%
10	secures 235 million	5	0.46%
11	surges on promising	4	0.37%
12	results with rly2608	4	0.37%
13	summit therapeutics secures	4	0.37%
14	with rly2608 in	4	0.37%
15	in early clinical	4	0.37%
16	in funding from	4	0.37%
17	million in funding	4	0.37%
18	bio til surges	4	0.37%
19	funding from leading	4	0.37%
20	rly2608 in breast	4	0.37%
21	monopar therapeutics’ mnpr	4	0.37%
22	12 2024 0	4	0.37%
23	in breast cancer	4	0.37%
24	breast cancer study	4	0.37%
25	promising tumor targeting	4	0.37%
26	therapeutics inc nasdaq	4	0.37%
27	til surges on	4	0.37%
28	sorrento therapeutics inc	3	0.28%
29	make it modern	3	0.28%
30	home contact us	3	0.28%

#	Keyword	Frequency	Density
1	secures 235 million in	5	0.45%
2	therapeutics’ mnpr mnpr101zr shows	5	0.45%
3	therapeutics secures 235 million	5	0.45%
4	on promising cancer therapy	5	0.45%
5	cancer therapy licensing deal	5	0.45%
6	promising cancer therapy licensing	5	0.45%
7	monopar therapeutics’ mnpr mnpr101zr	4	0.36%
8	results with rly2608 in	4	0.36%
9	summit therapeutics secures 235	4	0.36%
10	with rly2608 in breast	4	0.36%
11	million in funding from	4	0.36%
12	rly2608 in breast cancer	4	0.36%
13	in breast cancer study	4	0.36%
14	surges on promising cancer	4	0.36%
15	til surges on promising	4	0.36%
16	235 million in funding	4	0.36%
17	bio til surges on	3	0.27%
18	secures key patent solidifies	3	0.27%
19	home contact us about	3	0.27%
20	in funding from leading	3	0.27%
21	investors monopar therapeutics’ mnpr	3	0.27%
22	test systems nasdaq aehr	3	0.27%
23	mnpr mnpr101zr shows promising	3	0.27%
24	mnpr101zr shows promising tumor	3	0.27%
25	promising tumor targeting in	3	0.27%
26	a bold move to	3	0.27%
27	algs a bold move	3	0.27%
28	therapeutics algs a bold	3	0.27%
29	aligos therapeutics algs a	3	0.27%
30	solidifies leadership in advanced	3	0.27%
31	patent solidifies leadership in	3	0.27%
32	aehr test systems nasdaq	3	0.27%
33	key patent solidifies leadership	3	0.27%
34	contact us about us	3	0.27%
35	us about us advertise	3	0.27%
36	about us advertise biotech	3	0.27%
37	news tech stocks more	3	0.27%
38	tech news tech stocks	3	0.27%
39	profiles tech news tech	3	0.27%
40	targeting in early clinical	3	0.27%